pain m
Instructed in new medication Amoxicillin and in S/E such as lethargy, hallucinations, seizures, anxiety, confusion, agitation, depression, dizziness, fatigue, nausea, vomiting, diarrhea, glossitis, stomatitis, gastritis, abdominal pain, enterocolitis, pseudomembranous colitis, black tongue, interstitial nephritis, nephropathy, vaginitis, anemia, thrombocytopenia, thrombocytopenic purpura, eosinophilia, leukopenia, hemolytic anemia, agranulocytosis, hypersensitivity reactions, anaphylaxis, and overgrowth of nonsusceptible organisms.
Notify MD if rash, fever, or chills develop. A rash is the most common allergic reaction, especially if allopurinol is also being taken.
Instructed to contact physician inmediately if uncontrolled bleeding or excruciating pain occurs at wound site.
Instructed in signs and symptoms of complications and/or deterioration of wound status such as temperature above 100 grade, increase redness, drainage, edema, increase pain, increase size of wound.
Instructed in management and control of wound through activity such as frequent rest periods, no overexertion, no lifting, bending or stooping. Passive and active exercises to increase vascular tone. Elevate affected extremity to promote venous return. Give pain medication, if prescribed, 30 minutes prior to any activity.
Instructed in new medication Sulfaprim and in S/E such as headache, mental depression, aseptic meningitis, tinnitus, apathy, seizures, hallucinations, ataxia, nervousness, fatigue, vertigo, insomnia, thrombophlebitis, nausea, vomiting, diarrhea, abdominal pain, anorexia, stomatitis, pancreatitis, pseudomembranous colitis, toxic nephrosis with oliguria and anuria, crystalluria, hematuria, interstitial nephritis, agranulocytosis, aplastic anemia, megaloblastic anemia, thrombocytopenia, leukopenia, hemolytic anemia, jaundice, hepatic necrosis, arthralgia, myalgia, muscle weakness, pulmonary infiltrates, erythema multiforme, Stevens-Johnson syndrome, generalized skin eruption, toxic epidermal necrolysis, exfoliative dermatitis, photosensitivity, urticaria, pruritus, hypersensitivity reactions, serum sickness, drug fever and anaphylaxis.
Instructed in new medication Allopuriniol and in S/E such as drowsiness, fever, headache, paresthesia, peripheral neuropathy, neuritis, hypersensitivity vasculitis, necrotizing angiitis, epistaxis, nausea, vomiting, diarrhea, abdominal pain, gastritis, taste loss (or perversion, dyspepsia), renal failure, uremia, agranulocytosis, anemia, aplastic anemia, thrombocytopenia, leukopenia, leukocytosis, eosinophilia, hepatitis, hepatic necrosis, hepatomegaly, cholestatic jaundice, arthralgia, myopathy, rash, exfoliative, urticarial, and purpuric lesions, erythema multiforme, severe furunculosis of nose, ichthyosis, alopecia, toxic epidermal necrolysis, ecchymoses, chills.
Instructed in new medication Prevacid and in S/E such as headache, dizziness, vertigo, malaise, paresthesia, fever, palpitations, flushing, orbital edema, tinnitus, diarrhea, constipation, anorexia, taste perversion, dry mouth, bone and muscle pain, acne, dry skin and transient irritation at I.V. site.
Instructed in new medication Sinemet and in S/E such as choreiform, dystonic, dyskinetic movements, involuntary grimacing, head movements, myoclonic body jerks, ataxia, tremor, muscle twitching, bradykinetic episodes, psychiatric disturbances, anxiety, disturbing dreams, euphoria, malaise, fatigue, severe depression, suicidal tendencies, dementia, delirium, hallucinations (may necessitate reduction or withdrawal of drug), confusion, insomnia, agitation, orthostatic hypotension, cardiac irregularities, phlebitis, blepharospasm, blurred vision, diplopia, mydriasis or miosis, oculogyric crises, excessive salivation, dry mouth, bitter taste, nausea, vomiting, anorexia, constipation, flatulence, diarrhea, abdominal pain, urinary frequency, urine retention, urinary incontinence, darkened urine, priapism, hemolytic anemia, thrombocytopenia, leukopenia, agranulocytosis, hepatotoxicity, weight loss (may occur at start of therapy), hiccups, hyperventilation, and dark perspiration.
Instructed in new medication Xopenex to manage bronchospasm. In addition, warned of possible S/E such as dizziness, migraine, pain, tremor, anxiety, tachycardia, dyspepsia, leg cramps, increased cough, flu syndrome, accidental injury and viral infection.
Instructed to recognize S/S of Rheumatoid arthritis such as loss of appetite, fatigue, weakness, pain and tenderness of joint, weight loss, swelling, etc.